We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

EGESTA - Emergent GI Therapy for Severe, Complicated CDI Using Fecal Microbiota Transplant (EGESTA)

This study has been withdrawn prior to enrollment.
(Lack of eligible patients)
Sponsor:
ClinicalTrials.gov Identifier:
NCT02968511
First Posted: November 18, 2016
Last Update Posted: November 27, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
OpenBiome
Information provided by (Responsible Party):
David B. Stewart, MD, FACS, FASCRS, Milton S. Hershey Medical Center
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
  Study Status: This study has been withdrawn prior to enrollment.
  Study Completion Date: November 14, 2017
  Primary Completion Date: November 14, 2017 (Final data collection date for primary outcome measure)